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Abstract
Introduction Intraventricular hemorrhage (IVH) is mostly
documented in premature infants, and the younger the gesta-
tional age, the more often it occurs. IVH is very rarely reported
in full-term neonates.
Case report Retrospective analysis was performed in 35939
full-term neonates, who were born in the Clinical Hospital of
Gynecology and Obstetrics at the University of Medical
Sciences in Poznań. Clinical data were retrieved from their med-
ical records. We report a case series of 2 term newborns, who
developed severe IVH grade 3 and 4 with no evidence of as-
phyxia, neuroinfection, TORCH infections, coagulation disor-
ders and trombocytopenia, metabolic disorders, arteriovenous
malformations, and selected genetic abnormalities (factor V
Leiden 1601G > A polymorphism and MTHFR 677C > T;
1298A>C polymorphisms). IVH in both caseswas complicated
by posthemorrhagic hydrocephalus treated with decompressive
lumbar punctures and next ventriculoperitoneal shunt placement.
Conclusions In conclusion, several factors influence the pre-
disposition for severe IVH in term neonates. Perinatal period
complicated by fetal distress, birth trauma, and severe asphyx-
ia should be taken into account. However, it is possible that
etiopathogenesis cannot be defined clearly as in our cases.
Cranial ultrasounds in a specific group of term newborns (tak-
ing into account risk factors for IVH) should be widely
recommended.
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Introduction
Intraventricular hemorrhage (IVH) is mostly documented in
premature infants, and the younger the gestational age, the more
often it occurs [1]. IVH is very rarely reported in full-term neo-
nates and may occur in these children with a variety of clinical
conditions, mostly due to perinatal trauma, asphyxia, and coag-
ulation disorders. Very often, IVH in full-term neonates comes
from choroidal plexus and is connected with venous thrombosis
and ischemia of the thalamus. However, in some cases, it might
be a result of damage to the residual periventricular germinal
matrix. The high mortality rate in full-term newborns with
IVH is explained by perinatal asphyxia [2].
Retrospective analysis of 35939 full-term neonates was
performed. Children were born from January 1, 2009 to
December 31, 2014 in the Clinical Hospital of Gynecology
and Obstetrics at Poznan University of Medical Sciences.
Cranial ultrasounds were performed according to local stan-
dards. We reported two full-term babies suffering from grade
3 and 4 of IVH. The incidence rate of IVH grade 3 and 4 was
5.5 per 100,000 live term births.
Case 1
A 39-week gestation of male neonate weighing 3670 g was
born in good general condition by vaginal delivery to a 39-
year-old gravida 4, para 4 mother. The pregnancy was com-
plicated by maternal diabetes. Apgar scores were 9 at first
minute and then 9 and 10 at third and fifth minutes, respec-
tively. Umbilical cord pH was measured at 7.13 (BE
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−9.8 mEq/l) and 7.14 (BE −9.3 mEq/l). The amniotic fluid
was meconium-stained.
After delivery, the newborn presented tachypnea, radiolog-
ical signs of pneumonia, and increased inflammatory markers
(C-reactive protein concentration was 16.39 mg/l and white
blood cell count was 22.66 G/l). Further investigation showed
Proteus mirabilis from a throat swab and navel culture. The
patient was treated with broad-spectrum antibiotics for 7 days.
According to the results of laboratory tests, the neuroinfection,
TORCH (toxoplasmosis–other–rubella–cytomegalovirus–
herpesviridae) infections, coagulation disorders and
trombocytopenia, metabolic disorders, and selected genetic
abnormalities (factor V Leiden 1601G > A polymorphism
and MTHFR 677C > T; 1298A > C polymorphisms) were
excluded.
Birth tremors of the upper and lower limbs as well as in-
consolable cry were observed. On the third day of life, a single
episode of focal seizures of the left upper limb, increased
muscle tone in limbs (especially on the left side), excessive
tendon reflexes, and neck stiffness were presented. The first
cranial ultrasound was performed on the third day of life and
revealed extension of the both right and left lateral ventricles
with features of third stage IVH. In occipital areas, there were
hemorrhagic foci (fourth stage IVH according to papilla
criteria). In subsequent ultrasounds, we confirmed posthem-
orrhagic hydrocephalus.
Magnetic resonance imaging (MRI) showed in the right
hemisphere of the brain on the border of the temporoparietal
lobes, an intracerebral hematoma—transverse dimensions ap-
proximately 3 × 2 cm. A second, sized 2 × 1 cm was visible in
the left temporal lobe, at the lower left corner of the lateral
ventricle. The ventricular system was not displaced,
supratentorially dilated with significant asymmetric dilation
of lateral ventricles. Angio-MR showed the main intracranial
arterial trunks. There was no evidence of significant vascular
defect (Fig. 1).
Case 2
A male full-term neonate weighing 3840 g was born in good
general condition, by vaginal delivery to a first-time mother at
39 weeks of gestation. The pregnancy was without any com-
plications. Apgar scores were 9, 9 and 10 at first, third, and
fifth minutes, respectively. Umbilical cord pH was measured
at 7.06 (BE −12.1 mEq/l) and 7.14 (BE −10.5 mEq/l).
On the third day of life screening, cranial ultrasound (in
accordance with local recommendations in patients with pH
below 7.1) was performed. According to papilla criteria, IVH
stage 3 to the left lateral ventricle and stage 2 to the right
lateral ventricle were diagnosed. In subsequent ultrasounds,
performed every 3 days, we confirmed posthemorrhagic
hydrocephalus.
Laboratory tests and microbiological research excluded
neuro and intrauterine infection. Coagulation disorders and
thrombocytopenia, TORCH infections, selected genetic ab-
normalities (factor V Leiden (F5) 1601G >A polymorphism
andMTHFR 677C > T; 1298A > C polymorphisms), andmet-
abolic disorders were also excluded.
In neurologic assessment, a decreased muscle tone along
the head-torso axis and an increased tone in the upper and
lower limbs were detected. Physiotherapy treatment (Vojta
method) and stimulation of the sucking reflex were applied
during the time of hospitalization.
To verify the diagnosis and identify etiopathogenesis of
IVH on the 22nd day of life, the patient underwent MRI.
The MRI showed asymmetric, dilated ventricular system
and in both choroidal plexuses visualized posthemorrhagic
changes and in left choroidal plexus fresh bleeding focus. In
midline, straight under tentorium cerebella, there were signs
of fresh bleeding. Angio-MR did not show any vascular de-
fects and obstructions within the major intracranial arteries
(Fig. 2).
Both patients were discharged to the Department of
P ed i a t r i c Neu r o su rg e r y f o r f u r t h e r t r e a tmen t
(ventriculoperitoneal shunt placement). Patient reported as
case 1 developed cerebral palsy at age 18 months (diplegia
spastica) with non-verbal communications skills impairment.
In second child, at age 18 months, mild gross motor (walk on
Fig. 1 Brain magnetic resonance imaging of the neonate reported as case
1. The right hemisphere of the brain on the border of the temporoparietal
lobes, an intracerebral hematoma, second in the left temporal lobe
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knee and able to stand and walk with support) and fine motor
delays without any non-verbal communications skills impair-
ment or vision abnormalities were observed and required
physical therapy.
Discussion
Incidence and clinical features
IVH is an important source of neonatal morbidity and mortal-
ity. The incidence of IVH in term newborns is not known. The
incidence of all types of symptomatic intracranial hemor-
rhages (epidural, subdural, subarachnoid, intraventricular,
and intraparenchymal) is 0.27–0.49 per 1000 live births [1].
IVH in full-term infants usually occurs during labor due to
mechanical factors; however, in the preterm infants, it occurs
mostly as a result of the immature central nervous system and
hemodynamic instability. Besides etiology, the location of
hemorrhage, clinical presentation, and neurological outcome
also differs in the term and preterm infants. The term newborn
with IVH typically presents with signs such as seizures, apnea,
irritability or lethargy, and vomiting with dehydration.
Flaccidity, loss of pupillary reaction, extraocular movements,
coma, irritability, vomiting, shrill cry, central facial weakness,
opisthotonic posturing, fever or hypothermia, hypo- or hyper-
glycemia, decreased lower extremity tone, neck flexor hypo-
tonia, head lag, and brisk reflexes are less frequent in term
newborns, however more often observed in preterms. In both
cases described by us, seizures and increased muscle tone in
the limbs were observed [2–4]. In approximately 25 %, IVH
remains asymptomatic and can only be discovered on imaging
procedures. Significant advances in technology of cranial ul-
trasonography (universality, availability, no risk of radiation
exposure, and non-invasive procedure) allow it to be a good
choice for early identification of significant intracranial le-
sions in healthy full-term neonates [2–4].
Etiology and risk factors for IVH in full-term neonates
Most IVHs arise from the posterior tufts at the glomus in the
choroid plexus, and less commonly arise from the small resid-
ual germinal matrix tissue near the thalamocaudate groove,
the thalamus, and the watershed area of the foramen of
Monro near the caudate nucleus. The bleedings with higher
grades originatedmore often from choroid plexus [3, 5]. Some
arteriovenous malformations (AVM) may cause neonatal in-
tracranial hemorrhage. Reports of AVM of choroid plexus
have been limited to descriptions of individual cases [6].
IVH may be followed by development of venous sinus, med-
ullary, or cortical vein thrombosis [7]. In one third of cases, a
hemorrhage mechanism cannot be determined from neuroim-
aging studies [5]. Multifocal intraparenchymal hemorrhage
was found in the first reported case and choroid plexus hem-
orrhage in the second patient.
IVH bleeding in the full-term newborn may occur as a
result of birth asphyxia and resuscitation at birth [3, 5, 8, 9].
A significant clinical problem, which is generally regarded as
one of the risk factors of IVH, is asphyxia, a secondary con-
sequence to an interruption of placental blood flow and de-
creased blood flow to the brain and impairment of cerebral
autoregulation. Treatment with therapeutic hypothermia in ne-
onates with hypoxic ischemic encephalopathy may prevent
the development of severe brain injuries and improve the
long-term outcome. On the other hand, it places newborns at
greater risk of IVH by causing fluctuations of the cerebral
blood flow, depressed cardiac function, hypotension, and
changes in coagulation cascade [3]. It was demonstrated that
severe stages of HIE may lead to development of severe IVH
[10]. Fetal distress was identified as a significant risk factor for
IVH and may compromise the vascular environment and may
be the first sign of fetal compromise due to IVH in utero [5,
11]. However, since IVH itself may cause respiratory distress,
it is difficult to demonstrate that asphyxia is a significant factor
in IVH pathogenesis.
The vaginal birth process itself may be traumatic
enough to cause IVH in term newborns. Moreover, instru-
mental deliveries have been shown as a risk factor for IVH
in term newborns [12, 13], while other studies did not
confirm this association [5].
Fig. 2 Brain magnetic resonance imaging of the neonate reported as case
2. Hydrocephalus and posthemorrhagic changes in both choroid plexuses,
in the left choroid plexus fresh bleeding focus
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Bleeding disorders are rare cause of IVH in term newborns.
Thrombocytopenia (drug-induced, infectious, genetic, im-
mune-related) is a condition that may lead to IVH [8].
Coagulation factors deficiencies (vitamin K-dependent coag-
ulation factors deficiency, factor VIII and IX deficiency) have
been implicated with intracranial hemorrhage [14, 15].
Diagnosing and treating coagulopathic changes may help to
decrease the risk for IVH. Coagulopathy significantly in-
creases the risk for IVH, especially in patients treated with
extracorporeal membrane oxygenation, therapeutic hypother-
mia, and in children with severe congenital heart diseases
(secondary to altered hemodynamics or anticoagulant admin-
istration) [5].
Newborns described in our study were delivered vaginally
in good clinical condition, without any symptoms of asphyxia.
Congenital heart diseases, infections, and coagulation disor-
ders were also excluded. Characteristic of patients, clinical
presentation, risk factors, and source of bleeding in term new-
borns previously reported with IVH are shown in Table 1.
Today, the attention paid to genetic factors is increasing in
the development of IVH but their connection with IVH in the
newborn has been confirmed by few clinical studies, especial-
ly in preterm newborns. Polymorphisms in the Factor V
Leiden gene were associated with the atypical timing of
IVH. The methylenetetrahydrofolate reductase (MTHFR) var-
iant 677C > T polymorphism and a low 5-min Apgar score
additively increased the risk of IVH in preterm neonates
[16]. It should be noted that none of the patients in our study
present with factor V Leiden 1601G >A, MTHFR 677C > T;
1298A > C polymorphisms.
Outcomes following IVH in full-term neonates
Neurodevelopmental impairment has been reported in nearly
50 % of patients with IVH. More than half of survivors re-
quired physical therapy, and nearly half of them demonstrated
neurologic deficits. However, more than half of them present
with only mild neurological problems [5, 12, 17].
Treatment options for IVH
The treatment of newborns with IVH should be done by a
multidisciplinary team consisting of pediatricians, neuroradi-
ologists, pediatric neurologists, and neurosurgeons. Treatment
should be focused on adequate ventilation, feeding, preven-
tion of metabolic acidosis, and normalization of coagulation
disorders. Anticonvulsant therapy should be used to control
seizure activity. Transfusion with fresh frozen plasma and
platelets may be beneficial in newborns with IVH.
Neurosurgical intervention in patients with IVH should be
considered in posthemorrhagic hydrocephalus to relieve in-
creasing intracranial pressure or to drain hemorrhagic ventric-
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In conclusion, several factors influence the predisposition
for severe IVH in term neonates. A perinatal period compli-
cated by fetal distress, birth trauma, and severe asphyxia
should be taken into account. However, it is possible that
etiopathogenesis cannot be defined clearly as in our cases.
Cranial ultrasounds in a specific group of term newborns (tak-
ing into account risk factors for IVH) should be widely
recommended.
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